scholarly journals ANALISIS SINTASAN PARAMETRIK PADA PASIEN STROKE DENGAN PENDEKATAN DISTRIBUSI WEIBULL

2019 ◽  
Vol 8 (1) ◽  
pp. 55
Author(s):  
NI MADE SRI WAHYUNI ◽  
I WAYAN SUMARJAYA ◽  
NI LUH PUTU SUCIPTAWATI

Parametric survival analysis is one of the survival analysis that has a distribution of survival data that follows a certain distribution. Weibull distribution is a distribution that is often used in parametric survival analysis. The purpose of this study is to determine parametric survival models using the Weibull distribution and to determine  the factors that can influence the recovery of stroke patients. This study uses data on stroke patients in the Wangaya hospital, Denpasar in 2017. The best model obtained in this study is a model that consists of two predictor variables, namely the age and the body mass index (BMI).Therefore the  factors that can influence the recovery of stroke patients are age and BMI.

Author(s):  
Michael J. Crowther

In this article, I present the community-contributed stmixed command for fitting multilevel survival models. It serves as both an alternative to Stata’s official mestreg command and a complimentary command with substantial extensions. stmixed can fit multilevel survival models with any number of levels and random effects at each level, including flexible spline-based approaches (such as Royston–Parmar and the log-hazard equivalent) and user-defined hazard models. Simple or complex time-dependent effects can be included, as can expected mortality for a relative survival model. Left-truncation (delayed entry) is supported, and t-distributed random effects are provided as an alternative to Gaussian random effects. I illustrate the methods with a commonly used dataset of patients with kidney disease suffering recurrent infections and a simulated example illustrating a simple approach to simulating clustered survival data using survsim (Crowther and Lambert 2012, Stata Journal 12: 674–687; 2013, Statistics in Medicine 32: 4118–4134). stmixed is part of the merlin family (Crowther 2017, arXiv Working Paper No. arXiv:1710.02223; 2018, arXiv Working Paper No. arXiv:1806.01615).


2019 ◽  
Vol 29 (8) ◽  
pp. 2295-2306 ◽  
Author(s):  
MC Jones ◽  
Angela Noufaily ◽  
Kevin Burke

We are concerned with the flexible parametric analysis of bivariate survival data. Elsewhere, we argued in favour of an adapted form of the ‘power generalized Weibull’ distribution as an attractive vehicle for univariate parametric survival analysis. Here, we additionally observe a frailty relationship between a power generalized Weibull distribution with one value of the parameter which controls distributional choice within the family and a power generalized Weibull distribution with a smaller value of that parameter. We exploit this relationship to propose a bivariate shared frailty model with power generalized Weibull marginal distributions linked by the BB9 or ‘power variance function’ copula, then change it to have adapted power generalized Weibull marginals in the obvious way. The particular choice of copula is, therefore, natural in the current context, and the corresponding bivariate adapted power generalized Weibull model a novel combination of pre-existing components. We provide a number of theoretical properties of the models. We also show the potential of the bivariate adapted power generalized Weibull model for practical work via an illustrative example involving a well-known retinopathy dataset, for which the analysis proves to be straightforward to implement and informative in its outcomes.


Biomédica ◽  
2021 ◽  
Vol 41 (Sp. 2) ◽  
Author(s):  
Daniele Piovani ◽  
Georgios K. Nikolopoulos ◽  
Stefanos Bonovas

Non-parametric survival analysis has become a very popular statistical method in current medical research. Employing, however, survival methodology when its fundamental assumptions are not fulfilled can severely bias the results. Currently, hundreds of clinical studies are using survival methods to investigate factors potentially associated with the prognosis of Corona Virus Disease 2019 (Covid-19), and test new preventive and therapeutic strategies. In the pandemic era, it is more critical than ever that decision-making is evidence-based and relies on solid statistical methods. However, this is not always the case. Serious methodologic errors have been identified in recent seminal studies about Covid-19: one reporting outcomes of patients treated with remdesivir, and another one on the epidemiology, clinical course and outcomes of critically-ill patients. High-quality evidence is essential to inform clinicians about optimal Covid-19 therapies, and policymakers about the true effect of preventive measures aiming to tackle the pandemic. Though timely evidence is needed, we should encourage the appropriate application of survival analysis methods and careful peer-review to avoid publishing flawed results, which could affect decision-making. In this paper, we recapitulate the basic assumptions underlying non-parametric survival analysis and frequent errors in its application, and discuss how to handle data of Covid-19.


Sign in / Sign up

Export Citation Format

Share Document